人工耳蜗植入治疗鼻咽癌放疗后听力损失的系統综述
结果显示术中无并发症比例为80.4%(95%CI: 55.1-96.7),术后无并发症比例为96.5%(95%CI: 88.3-99.5),91.3%的患者(95%CI: 73.1-98.8)听力阈值改善,言语感知与患者报告结局亦有提升。结论认为该干预总体安全有效,支持放疗后常规听力学监测以及时转诊康复。
要点
- 鼻咽癌放疗后人工耳蜗植入总体安全,术后无并发症比例达96.5%。
- 91.3%的患者术后听力阈值改善,言语感知与生活质量亦有获益。
- 植入前重度听力损失平均病程6.5年,提示长病程患者仍可获益。
核心结论
- 鼻咽癌放疗后人工耳蜗植入总体安全有效,可提供有意义的听觉与功能获益,即使听力损失病程较长。
- 研究结果支持放疗后常规听力学监测以及时转诊康复。
研究设计与样本
- 系统综述,检索CINAHL、Cochrane Library、PubMed和Scopus自建库至2026年2月。
- 使用牛津证据等级和Joanna Briggs Institute工具评估研究质量与偏倚风险。
主要发现
- 术中无并发症比例为80.4%(95%CI: 55.1-96.7)。
- 术后无并发症比例为96.5%(95%CI: 88.3-99.5)。
- 91.3%的患者(95%CI: 73.1-98.8)听力学检查显示改善。
- 言语感知与患者报告结局均有提升。
- 植入前重度听力损失平均病程为6.5年。
关键数值与推荐
- 最常用手术方式为标准乳突切开加后鼓室切开,替代入路选择性使用。
- 手术与设备相关并发症不常见。
临床怎么用
- 对鼻咽癌放疗后患者应常规进行听力学监测,及时发现听力损失并转诊评估人工耳蜗植入。
- 即使重度听力损失病程较长(平均6.5年),人工耳蜗植入仍可考虑用于听觉康复。
局限性
- 证据等级为NA,研究质量与偏倚风险需结合原始研究解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate the safety and efficacy of cochlear implantation for auditory rehabilitation in patients with nasopharyngeal carcinoma (NPC) after radiation. DATA SOURCES: CINAHL, Cochrane Library, PubMed, and Scopus were searched from inception through February 2026. REVIEW METHODS: Studies reporting cochlear implantation for hearing loss after radiation for NPC were included. Subjective and objective measures of hearing, including thresholds, speech perception, quality-of-life outcomes, and surgical complications, were extracted. Pooled means and proportions with 95% confidence intervals (CI) were calculated for available outcomes using random-effects models. Study quality and risk of bias were assessed using Oxford Levels of Evidence and Joanna Briggs Institute critical appraisal tools. RESULTS: Twelve studies (N = 69 ears) were included. Cochlear implantation was most commonly performed via standard mastoidectomy with posterior tympanotomy, with alternative approaches used selectively. Surgical and device-related complications were uncommon, with 80.4% (95% CI: 55.1-96.7) without intraoperative complications and 96.5% (95% CI: 88.3-99.5) without postoperative complications. Audiometric improvement was observed in 91.3% of patients (95% CI: 73.1-98.8), with gains in speech perception and patient-reported outcomes. Mean duration of profound hearing loss prior to implantation was 6.5 years. CONCLUSION: Cochlear implantation after radiation in patients with NPC is generally safe and effective, providing meaningful auditory and functional benefits even in long-standing hearing loss. These findings support routine audiologic surveillance after radiation to enable timely referrals for rehabilitation. LEVEL OF EVIDENCE: NA.
引用
- Roberts KA, Williamson LE, Nguyen SA, et al. Cochlear Implants for Radiation-Induced Hearing Loss in Nasopharyngeal Cancer: A Systematic Review. Laryngoscope. 2026. PMID: 42811759. doi:10.1002/lary.70952
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。